ALEXANDRIA, Va., Jan. 13 -- United States Patent no. 12,522,653, issued on Jan. 13, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.).

"Antibody that binds to VEGF-A and ANG2 and methods of use" was invented by Roland Beckmann (Penzberg, Germany), Sebastian Fenn (Penzberg, Germany), Guido Hartmann (Basel, Switzerland), Sabine Imhof-Jung (Penzberg, Germany), Kristian Hobolt-Jensen (Penzberg, Germany), Joerg Moelleken (Penzberg, Germany), Michael Molhoj (Penzberg, Germany), Christian Schantz (Penzberg, Germany), Janina Speck (Penzberg, Germany), Christoph Ullmer (Basel, Switzerland) and Barbara Weiser (Penzberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a...